Clinical trial
A Prospective Observational Study of Neutropenia and Anemia Management in Subjects With Solid Tumors Receiving Myelotoxic Chemotherapy
NCT00883181 is registered in ClinicalTrials.gov with Amgen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Observational Study of Neutropenia and Anemia Management in Subjects With Solid Tumors Receiving Myelotoxic Chemotherapy
- Lead sponsor
- Amgen
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2006
- Completion date
- September 30, 2014
- Enrollment
- 1,370 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, non-small cell lung cancer, ovarian cancer, small cell lung cancer